Doxylamine Succinate and Pyridoxine Hydrochloride Tablet, Delayed Release — FDA Drug Shortage

To Be Discontinued — Mylan Pharmaceuticals Inc., A Viatris Company

The FDA lists a drug shortage record for Doxylamine Succinate and Pyridoxine Hydrochloride Tablet, Delayed Release (tablet) from Mylan Pharmaceuticals Inc., A Viatris Company with status To Be Discontinued. The shortage was first posted on Jan 12, 2026.

Shortage details

Status
To Be Discontinued
Company
Mylan Pharmaceuticals Inc., A Viatris Company
Package NDC
0378-4615-01
Dosage Form
Tablet
Presentation
Doxylamine Succinate and Pyridoxine Hydrochloride, Tablet, Delayed Release, 10 mg; 10 mg (NDC 0378-4615-01)
Initial Posting
Jan 12, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.